Administrative Suspension of Tablet Formulation Manufacturing for 15 Days (Pharmaceutical Law Violation)
-
Administrative suspension of tablet formulation manufacturing for 15 days (May 22 - June 5, 2026) due to Pharmaceutical Affairs Act violation
-
Affected sales: KRW 199.9 billion (68.15% of recent sales of KRW 293.3 billion)
-
No impact on other formulations, sales, or distribution; sufficient inventory secured
-
Products manufactured before suspension can be distributed and sold
KOSDAQ Filing Information
-
Filing: Suspension of Production
-
Company: AHN-GOOK PHARMACEUTICAL (001540)
-
Submission: AHN-GOOK PHARMACEUTICAL Co., Ltd.
-
Receipt: 05-08-2026
-
Under KRX KOSDAQ Market Division